Clinical-stage biotechnology company
Appears in 1 story
Filing sonelokimab for U.S. approval in hidradenitis suppurativa
Hidradenitis suppurativa causes painful, recurring abscesses in the skin folds of about 1 in 100 people. For most of the past decade, one drug controlled it well enough to win U.S. approval. MoonLake now wants to change that.
Updated Yesterday
No stories match your search
Try a different keyword
How would you like to describe your experience with the app today?
